EGFR and cancer: As summarized in Figure 1, the EGFR is deregulated, in several types of cancer, by three fundamental mechanisms: (i) activating gene mutations; (ii) overexpression of the EGFR trans-membrane form (via gene amplification or polysomy) and (iii) altered ligand expression (with the possible formation of autocrine loops) [13].